AI Agent Operational Lift for Katecho, Llc in Des Moines, Iowa

Why AI matters at this scale

Katecho, LLC is a Des Moines-based contract manufacturer specializing in medical electrodes and devices. With 201-500 employees and a history dating back to 1984, the company operates in the high-stakes, FDA-regulated surgical and medical instrument manufacturing sector (NAICS 339112). As a mid-market player, Katecho likely generates an estimated $45M in annual revenue by producing high-mix, low-to-medium volume components for larger OEMs. This size band is a sweet spot for AI adoption: large enough to have accumulated meaningful production data, yet small enough to implement changes rapidly without the bureaucratic inertia of a mega-corporation.

The data-rich environment of medical device contract manufacturing

Every batch of electrodes generates a wealth of structured data—material lot numbers, mixing times, curing temperatures, inline test results, and final quality assurance metrics. This data is often underutilized, residing in ERP systems like IQMS or SAP Business One and quality management systems like MasterControl. AI can unlock this latent value, transforming reactive quality control into predictive process optimization. For a company of this size, even a 5% reduction in scrap can translate to over $1M in annual savings, making the ROI case compelling.

Three concrete AI opportunities

1. Predictive quality and process optimization

The highest-impact opportunity lies in applying supervised machine learning to historical batch records. By training models on the relationship between process parameters (gel viscosity, ambient humidity, cure time) and final adhesion strength, Katecho can predict failures before they occur. This reduces costly rework and prevents out-of-spec product from reaching clients. The ROI is direct: lower material waste, fewer quality holds, and stronger supplier ratings from OEMs.

2. AI-driven production scheduling

Katecho likely manages multiple cleanroom lines with frequent changeovers between electrode types. Reinforcement learning algorithms can optimize job sequencing to minimize downtime, balance labor loads, and improve on-time delivery. This is a medium-complexity project that builds on existing MES data and can yield a 10-15% throughput increase without capital expenditure on new equipment.

3. Automated visual inspection

Electrode placement and gel coating are precision processes where micro-defects can cause device failure. Deploying computer vision cameras on existing lines, trained on thousands of labeled images of good and defective products, can catch anomalies in real time. This reduces reliance on manual inspection, speeds up throughput, and provides a digital audit trail that supports FDA compliance.

Deployment risks and mitigation

For a mid-market manufacturer, the primary risks are not technical but organizational. Data silos between engineering, quality, and production can stall model development. A cross-functional AI team with executive sponsorship is essential. Second, model validation in a regulated environment requires careful documentation; partnering with a quality assurance consultant familiar with FDA's emerging guidance on AI/ML in medical devices mitigates this. Finally, change management is critical—technicians may distrust black-box recommendations. Starting with a transparent, assistive model that explains its reasoning builds trust and adoption.